NCT03052283Recruiting
Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score)
Evaluation and Validation of a New Questionnaire to Identify and Quantify Abdominal Symptoms in Patients With Cystic Fibrosis Following FDA Guidelines: the CF Abd-Score (Primarily Named JenAbdomen-CF Score)
Source: ClinicalTrials.gov · Last updated 4 Apr 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Development, validation and evaluation of a new multimodal questionnaire to assess and quantify the abdominal involvement in patients with the inherited life shortening multi-organ disease Cystic fibrosis. In the stepwhise development of the patient reported outcome measures (PROM) repeadedly, CF-patients, their families as well as professionals working in different fields of CF-care will be included.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 9 Feb 2017
- Start date
- 26 Jan 2017
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Medizinische Hochschule Brandenburg Theodor Fontane
- Diseases
- Cystic fibrosis
- NCT number
- NCT03052283
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 26 Jan 2017 to the primary completion date, 31 Dec 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other diseases causing abdominal symptoms (Inflammatory bowel disease (IBD), alpha 1 antitrypsin deficiency, celiac disease, food allergy, gastroenteritis, etc.)
Other
- CF cohort:
- Lacking ability to cooperate of patients /their families, respectively
- Healthy controls:
Who the study is looking for
- CF cohort:
- Diagnosis of CF determined by
- a sweat chloride of \>60 mEq/L and/or
- detection of 2 disease causing CFTR mutations with evidence of organ involvement.
- Healthy controls:
- Age-matched
Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medizinische Hochschule Brandenburg (MHB), University Coordinator of this site? Confirm its status | Brandenburg an der Havel | Germany | Recruiting |
| Klinikum Westbrandenburg Coordinator of this site? Confirm its status | Brandenburg an der Havel | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.